by newsworm | Dec 19, 2024 | Pharma
Boston Institute of Biotechnology, LLC (BIB) and its sister company BiBo Pharma, leading Contract Development and Manufacturing Organizations (CDMOs) in large-molecule biologics, have announced a significant investment to expand their production capacity. This... by newsworm | Dec 19, 2024 | Pharma
The article discusses the growing trend of pro bono work in the healthcare communications industry, where agencies offer their services for free to organizations that need support. The author argues that while doing good is a benefit, there are also benefits for the... by newsworm | Dec 19, 2024 | Pharma
Vertex Pharmaceuticals Inc. (VRTX) recently released results from its Phase 2 study of suzetrigine, an investigational oral investigational medication for the treatment of patients with urea cycle disorders (UCDs). The open-label study evaluated the safety, efficacy,... by newsworm | Dec 19, 2024 | Pharma, Zydus
Zydus Lifesciences, a leading pharmaceutical company in India, has received approval from the US Food and Drug Administration (USFDA) for its generic version of a topical anaesthetic cream, Lidoderm (5% Lidocaine Topical Patch). The cream is used to treat pain... by newsworm | Dec 19, 2024 | Pharma
The biotech industry is rapidly expanding, driven by the need for global disease prevention and pandemic preparedness. To stay ahead of the game, biotech professionals need to master key skills. The top three essential skills in 2025 are: 1. Data Science &... by newsworm | Dec 19, 2024 | Pharma
A top UN official is urging world powers and Iran to work urgently to restore the 2015 Iran nuclear deal, which lifted sanctions on Tehran in return for curbs on its nuclear program. The official made the call on Tuesday, December 18, 2024. The deal, known as the... by newsworm | Dec 19, 2024 | Pharma
The DREAM-HF trial, a Phase III study sponsored by Mesoblast, has yielded promising results in the treatment of heart failure (HF). The study evaluated the safety and efficacy of Mesoblast’s allogenic mesenchymal precursor cells (MPCs) in patients with advanced... by newsworm | Dec 19, 2024 | Pharma
The Holly Springs Town Council has approved the use of land in the Holly Springs Business Park for the construction of a high school focused on life sciences. Pine Springs Preparatory Academy, which currently serves students from kindergarten to eighth grade, will... by newsworm | Dec 19, 2024 | Pharma
Pharmaceutical companies have been making notable announcements in recent times. Eli Lilly’s Alzheimer’s treatment, Kisunla, has been approved in China, bringing the total number of countries where it is approved to four – including the US, Japan,... by newsworm | Dec 18, 2024 | Lupin, Pharma
The US Food and Drug Administration (FDA) has approved a new treatment for HIV-1 infection by Lupin, a leading pharmaceutical company. The medication is intended to treat certain patients with HIV-1, a type of human immunodeficiency virus (HIV).